Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / Common stock, $0.001 par value
-
Shares outstanding
-
63,223,223
-
Total 13F shares
-
20,370,513
-
Share change
-
-8,842,340
-
Total reported value
-
$385,285,843
-
Put/Call ratio
-
4.3%
-
Price per share
-
$18.91
-
Number of holders
-
75
-
Value change
-
-$166,979,987
-
Number of buys
-
40
-
Number of sells
-
40
Institutional Holders of TREACE MEDICAL CONCEPTS, INC. - Common stock, $0.001 par value (TMCI) as of Q1 2022
As of 31 Mar 2022,
TREACE MEDICAL CONCEPTS, INC. - Common stock, $0.001 par value (TMCI) was held by
75 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
20,370,513 shares.
The largest 10 holders included
ALLIANCEBERNSTEIN L.P., VANGUARD GROUP INC, NEXT CENTURY GROWTH INVESTORS LLC, BlackRock Inc., CIBC Private Wealth Group, LLC, PERCEPTIVE ADVISORS LLC, TimesSquare Capital Management, LLC, EMERALD ADVISERS, LLC, EMERALD MUTUAL FUND ADVISERS TRUST, and JANUS HENDERSON GROUP PLC.
This page lists
74
institutional shareholders reporting positions in this security
for the Q1 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.